Insider buying
~$121K100K sh @ $1.21
First insider buy since Aug 2025Traded Nov 17 · filed 1 day later
Since the trade +9.4% · S&P 500 −2.3% · to Nov 19
Bought 34% below the 52-week high, RSI 42, 9% above its 200-day average, 11 points behind the S&P 500 over 3 months
The CEO of Maxcyte paid $121K out of pocket for Maxcyte shares. It was the first purchase in 15 months. Shares held went up 21% with this purchase.